Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 drug, researchers recently reported in JAMA Network Open. Patients were also ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says.

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could transform treatment for millions struggling with device therapies.

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

Sleep technology is moving beyond tracking, as device makers and health groups focus on shaping sleep, writes ARTHUR GOLDSTUCK.

New research shows long-term sleep problems may change gut bacteria, increasing inflammation and health risks beyond the ...

The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly ( LLY +0.53%) has been soaring in ...

Beyond disrupting sleep, untreated OSA is linked to serious health risks, including high blood pressure, heart disease, stroke, and metabolic disorders. That’s why early recognition isn’t just about ...

Doctors say frequent yawning can indicate deeper health issues. If you’re a chronic, compulsive yawner then don’t ignore it ...